Helmholtz Zentrum München

Epstein-Barr virus: Helmholtz Munich and DZIF are working on a vaccineThe Epstein-Barr virus (EBV) has been known for some time to play a part in a range of diseases. A current US study has now shown a close link between EBV and multiple sclerosis. Scientists at Helmholtz Munich and DZIF are already working on developing a vaccine that could move to clinical trials as early as 2023.

Novel interactions between genetics and epigenetics give clues about environmentally triggered diseasesThe interplay of genetics and epigenetics is a long-sought riddle in the development of diseases. Researchers from Helmholtz Munich and the Imperial College London discovered novel interactions.

Scientists dive deep into the different effects of morning and evening exerciseExercise causes the body to release hundreds of different signals that improve our health in many different ways

Helmholtz Munich wins three new ERC Starting GrantsHelmholtz Munich starts the new year with a triple success: Together with early-career scientists, the research center acquires three ERC Starting Grants from the European Research Council (ERC).

A light in the dark tissue: Switchable proteins for biomedical imagingTracking very few cells over time without damaging them is a key challenge in health research. For this purpose, Helmholtz Munich researchers engineer natural tools: switchable proteins.

Our mission: Discover personalized medical solutions for environmentally triggered diseases to promote a healthier society in a rapidly changing world.

Coronavirus Update

Due to the ongoing coronavirus pandemic, some precautions are being taken on the premises of Helmholtz Zentrum München to protect employees from infection and to contain the spread of the coronavirus. All measures are constantly being reviewed. Further information on the current regulations and our contribution to the fight against the pandemic can be found by following the link below.

more >

Departments

Diabetes

Environmental Health

Bioengineering

Computational Health

Stem Cell

Molecular Targets and Therapeutics Center

Helmholtz Pioneer Campus

Helmholtz Pioneer Campus

The Helmholtz Pioneer Campus is an innovation campus with a startup culture at the Helmholtz Zentrum München. HPC stands for the intelligent fusion of biomedical sciences, engineering and digitization. Teams of top scientific talents from all over the world work together on the development of novel solutions that make a difference in the prevention, diagnosis and treatment of diseases.

more >